Deal Watch: A Closer Look At Boehringer Ingelheim’s Partnering Strategy

Plus deals involving AbbVie/Ripple, Novo Nordisk/Korro Bio, Novo Nordisk/NanoVation, Bharat, Alopexx, Gilead/Genesis, Lilly/Genetic Leap, Contraline/Population Council, Proveca/Cessatech, Vivtex/Equillium and more.

Deal Watch 2021 — • Source: Shutterstock

Scrip regularly covers business development and deal making in the biopharmaceutical industry. Deal Watch is supported by deal intelligence from Biomedtracker.

Boehringer Ingelheim GmbH is closely held, owned mainly by members of three families, but it tries to compete with...